n-Lorem Foundation Identifies New, Important Roles of JIP3, Offering Critical Insights into Therapeutic Approaches for Nano-rare Patients
Research, supported by the [...]
n-Lorem Foundation Celebrates Five Years of Bringing Hope and Potential Treatments to Nano-rare Patients
Demand from the nano-rare [...]
Multi-year Grant from National Institutes of Health URGenT Network Funds Treatment of Patients with Ultra-Rare CHCHD10-ALS
$15 million grant supports [...]
GondolaBio and n-Lorem Foundation Partner to Advance Novel ASO Therapies for Genetic Diseases
Collaboration provides GondolaBio access [...]
n-Lorem Publishes Recommendations for Treating Patients with Heterozygous Toxic Gain of Function Mutations
Article published in Nucleic [...]
Positive Clinical Observations from n-Lorem Treated, KIF1A Nano-rare Patient Published in Nature Medicine
Case study, published in [...]
n-Lorem Foundation Names Andrew W. Lo as a New Member of its Board of Directors
Andrew Lo’s expertise in [...]
n-Lorem Foundation Welcomes New Member Alan Lotvin to its Board of Directors
Alan Lotvin’s expertise in [...]
